Immuneering (IMRX) Other Non Operating Income (2021 - 2026)

Immuneering's Other Non Operating Income history runs 6 years deep, the most recent figure standing at $513735.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income changed N/A year-over-year to $513735.0 in Q1 2026; TTM through Mar 2026 was $825400.0, a 261.29% increase from a year earlier, with the FY2025 full-year figure at $311665.0, down 29.41% from the prior year.
• Other Non Operating Income climbed to $513735.0 in Q1 2026 per IMRX's latest filing, from $311665.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $513735.0 in Q1 2026 and bottomed at -$103218.0 in Q1 2022.
• The 5-year median for Other Non Operating Income is $181615.0 (2023), against an average of $201286.1.
• Across the five-year window, Other Non Operating Income jumped 1593.82% in 2022 and slumped 94.86% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $223278.0 in 2022, then surged by 107.97% to $464352.0 in 2023, then slumped by 80.31% to $91430.0 in 2024, then soared by 240.88% to $311665.0 in 2025, then jumped by 64.84% to $513735.0 in 2026.
• Per Business Quant, the three latest IMRX Other Non Operating Income figures stand at $513735.0 (Q1 2026), $311665.0 (Q4 2025), and $91430.0 (Q4 2024).